Ketamine is an FDA approved drug. However, ketamine IV infusion therapy is considered an off-label treatment for mental health and chronic pain conditions. There are multiple scientific articles and clinical trials reporting its efficacy when used to treat many conditions. Many sources are currently working on both FDA approval, and insurance reimbursement.
We continue to provide treatments with positive outcomes as do multiple health care providers throughout the world. Medicare, Medicaid, and private insurance carriers do not pay for this treatment. Ketamine infusions are an out-of-pocket expense. We are hopeful this will change soon. We do our best to keep our fees affordable.